Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 87 (1-3) , 177-186
- https://doi.org/10.1016/s0168-3659(02)00362-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interleukin 12 Gene Therapy of Cancer by Peritumoral Injection of Transduced Autologous Fibroblasts: Outcome of a Phase I StudyHuman Gene Therapy, 2001
- Interleukin 12 Gene Transfer into Skin Distant from the Tumor Site Elicits Antimetastatic Effects Equivalent to Local Gene TransferHuman Gene Therapy, 2001
- Retroviral Expression ofEscherichia coliThymidylate Synthase cDNA Confers High-Level Antifolate Resistance to Hematopoietic CellsHuman Gene Therapy, 2001
- Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinomaCancer Gene Therapy, 2000
- Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsGene Therapy, 1998
- Comparison of the Protection of Cells from Antifolates by Transduced Human Dihydrofolate Reductase MutantsHuman Gene Therapy, 1997
- Murine Models of Cancer Cytokine Gene Therapy Using Interleukin‐12aAnnals of the New York Academy of Sciences, 1996
- Clinical Trials: IL-12 Deaths: Explanation and a PuzzleScience, 1995
- Multiple Effects on Peripheral Hematology Following Administration of Recombinant Human Interleukin 12 to Nonhuman PrimatesBiochemical and Biophysical Research Communications, 1994
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993